Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.

Imipenem-cilastatin was evaluated for efficacy and toxicity as an antistaphylococcal agent in 23 patients; 11 of these patients were infected with methicillin-resistant Staphylococcus aureus (MRSA), and 12 were infected with methicillin-susceptible S. aureus (MSSA). There were 15 soft tissue, 5 endo...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Fan, W, del Busto, R, Love, M, Markowitz, N, Cendrowski, C, Cardenas, J, Quinn, E, Saravolatz, L
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1986
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180357/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3460521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.1.26
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!